Effect of subcutaneous recombinant human parathyroid hormone, rhPTH(1--84), on skeletal dynamics in hypoparathyroidism: findings from the 24-week replace and 8-week relay phase III clinical trials
John P Bilezikian, Gerard Maruani, Jeffrey Rothman, Bart L Clarke, Michael Mannstadt, Tamara Vokes, Hjalmar Lagast & Dolores M Shoback